State NJ
Clinical Trials in New Jersey
Recruiting clinical trials with at least one study location in New Jersey. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Jersey
NCT06847685 N/A
Recruiting
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
Condition
Endometriosis
Enrollment
140 pts
Location
United States
Sponsor
Johns Hopkins University
NCT04872543 Phase 2
Recruiting
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNS...
Condition
Malignant Peripheral Nerve Sheath Tumors (MPNST)
Enrollment
25 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07210021 N/A
Recruiting
AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy...
Condition
Hyperkalemia
Enrollment
50 pts
Location
United States
Sponsor
AccurKardia, Inc.
NCT07029217 Phase 3
Recruiting
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
Condition
Follicular Lymphoma
Enrollment
375 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT02296450 N/A
Recruiting
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatolo...
Condition
Cancer
Enrollment
1,025 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05801861 N/A
Recruiting
Modulating Goal-directed Navigation Using Noninvasive Brain Stimulation
Condition
Spatial Navigation
Enrollment
60 pts
Location
United States
Sponsor
Rutgers, The State University
NCT07105059 Phase 1
Recruiting
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Condition
Multiple Myeloma
Enrollment
18 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT04485013 Phase 1
Recruiting
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Condition
Cancer
Enrollment
240 pts
Location
United States
Sponsor
Tizona Therapeutics, Inc
NCT06297291 N/A
Recruiting
Global Paradise System US Post Approval Study
Condition
Hypertension
Enrollment
1,000 pts
Location
United States
Sponsor
ReCor Medical, Inc.
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Condition
Colorectal Cancer
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT04641247 Phase 2
Recruiting
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed...
Condition
Ovarian Neoplasms
Enrollment
30 pts
Location
United States, Austria, Canada
Sponsor
GlaxoSmithKline
NCT06907147 N/A
Recruiting
SPYRAL GEMINI Pilot Study
Condition
Hypertension
Enrollment
175 pts
Location
United States, Australia, Greece
Sponsor
Medtronic Vascular
NCT07217535 N/A
Recruiting
Rutgers University Study of the Genetics of Kidney Disease
Condition
Kidney Disease
Enrollment
50,000 pts
Location
United States
Sponsor
Rutgers, The State University
NCT07024784 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events in Adult Partici...
Condition
Gynecologic Cancers
Enrollment
377 pts
Location
United States, Israel, Japan
Sponsor
AbbVie
NCT06362252 Phase 1, Phase 2
Recruiting
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as...
Condition
Extensive Stage-small Cell Lung Cancer
Enrollment
123 pts
Location
United States, France, Japan
Sponsor
Daiichi Sankyo
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
NCT05269316 Phase 1, Phase 2
Recruiting
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Ad...
Condition
Solid Tumor
Enrollment
61 pts
Location
United States, Australia, China
Sponsor
Impact Therapeutics, Inc.
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care i...
Condition
DLBCL
Enrollment
290 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05482516 Phase 3
Recruiting
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Condition
Colon Adenocarcinoma
Enrollment
20 pts
Location
United States
Sponsor
Georgetown University
NCT07209449 Phase 2
Recruiting
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With E...
Condition
Endometrial Cancer
Enrollment
75 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06243718 N/A
Recruiting
Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis: Patie...
Condition
Diaphragmatic Paralysis
Enrollment
45 pts
Location
United States
Sponsor
Advanced Reconstructive Surger
NCT07216482 Phase 3
Recruiting
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-03...
Condition
Hyperlipidemia
Enrollment
975 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05534243 N/A
Recruiting
The ED-AWARENESS-2 Trial
Condition
Awareness
Enrollment
3,090 pts
Location
United States
Sponsor
Washington University School o
NCT06339008 Phase 3
Recruiting
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (...
Condition
Perennial Allergic Rhinitis (PAR)
Enrollment
450 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company